Insitro Raises $400M in Series C

18 Mar, 2021

Insitro Raises $400M in Series C
Photo by Denise Jans on Unsplash

– Insitro, a machine learning-driven drug discovery and development company, has raised $400m in a Series C financing.
– The financing was led by Canada Pension Plan Investment Board (CPP Investments), with significant participation from current investors Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., Casdin Capital, and funds and accounts managed by BlackRock as well as ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, HOF Capital and Alexandria Venture Investments.

Biotechnology Life Science North America Pharmaceutical Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: